Hypersensitivity to empagliflozin or any of the excipients in JARDIANCE.
In case of rare hereditary conditions that may be incompatible with an excipient of the product, the use of the product is contraindicated. The JARDIANCE 10 mg tablet contains 162.5 mg of lactose monohydrate and the JARDIANCE 25 mg tablet contains 113 mg of lactose monohydrate per maximum recommended daily dose. Patients with the rare hereditary conditions of galactose intolerance e.g. galactosaemia should not take this medicine.